Bruce & Co’s Merck MRK Stock Holding History

Bruce & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.2M	Hold	192,800	–	–	6.63%	5
2025 Q4	$20.3M	Hold	192,800	–	–	6.29%	6
2025 Q3	$16.2M	Hold	192,800	–	–	5.01%	8
2025 Q2	$15.3M	Sell	192,800 -10,000	-5%	-$795K	4.95%	9
2025 Q1	$18.2M	Sell	202,800 -10,000	-5%	-$934K	5.84%	8
2024 Q4	$21.2M	Sell	212,800 -1,700	-0.8%	-$175K	6.8%	5
2024 Q3	$24.4M	Sell	214,500 -10,000	-4%	-$1.19M	7.09%	5
2024 Q2	$27.8M	Buy	224,500 +3,800	+2%	+$489K	9.14%	2
2024 Q1	$29.1M	Hold	220,700	–	–	9.66%	2
2023 Q4	$24.1M	Hold	220,700	–	–	8.4%	2
2023 Q3	$22.7M	Sell	220,700 -79,672	-27%	-$8.59M	7.74%	3
2023 Q2	$34.7M	Hold	300,372	–	–	9.72%	1
2023 Q1	$32M	Sell	300,372 -2,328	-0.8%	-$251K	8.71%	2
2022 Q4	$33.6M	Sell	302,700 -21,000	-6%	-$2.15M	8.66%	2
2022 Q3	$27.9M	Hold	323,700	–	–	7.66%	4
2022 Q2	$29.5M	Hold	323,700	–	–	6.94%	7
2022 Q1	$26.6M	Hold	323,700	–	–	5.43%	10
2021 Q4	$24.8M	Hold	323,700	–	–	4.96%	12
2021 Q3	$24.3M	Sell	323,700 -6,500	-2%	-$494K	5.17%	10
2021 Q2	$25.7M	Sell	330,200 -12,391	-4%	-$922K	4.9%	11
2021 Q1	$25.2M	Hold	342,591	–	–	4.72%	11
2020 Q4	$26.7M	Hold	342,591	–	–	5.15%	11
2020 Q3	$27.1M	Hold	342,591	–	–	5.62%	10
2020 Q2	$25.3M	Hold	342,591	–	–	5.49%	9
2020 Q1	$25.2M	Hold	342,591	–	–	5.8%	7
2019 Q4	$29.7M	Hold	342,591	–	–	5.8%	6
2019 Q3	$27.5M	Buy	342,591 +4,192	+1%	+$336K	5.71%	7
2019 Q2	$27.1M	Sell	338,399 -38,252	-10%	-$2.93M	5.77%	6
2019 Q1	$29.9M	Hold	376,651	–	–	5.84%	6
2018 Q4	$27.5M	Hold	376,651	–	–	5.85%	5
2018 Q3	$25.5M	Hold	376,651	–	–	4.94%	7
2018 Q2	$21.8M	Hold	376,651	–	–	4.34%	8
2018 Q1	$19.6M	Buy	376,651 +104,800	+39%	+$5.66M	4.09%	10
2017 Q4	$14.6M	Hold	271,851	–	–	3.16%	12
2017 Q3	$16.6M	Hold	271,851	–	–	3.71%	10
2017 Q2	$16.6M	Hold	271,851	–	–	3.8%	9
2017 Q1	$16.5M	Hold	271,851	–	–	3.95%	8
2016 Q4	$15.3M	Hold	271,851	–	–	3.99%	7
2016 Q3	$15.8M	Hold	271,851	–	–	4.28%	7
2016 Q2	$14.9M	Hold	271,851	–	–	3.82%	9
2016 Q1	$13.7M	Hold	271,851	–	–	3.83%	8
2015 Q4	$13.7M	Hold	271,851	–	–	3.72%	10
2015 Q3	$12.8M	Hold	271,851	–	–	3.29%	7
2015 Q2	$14.8M	Hold	271,851	–	–	3.82%	7
2015 Q1	$15M	Hold	271,851	–	–	3.82%	6
2014 Q4	$14.7M	Sell	271,851 -5,869	-2%	-$327K	4.07%	7
2014 Q3	$15.5M	Buy	277,720 +3,668	+1%	+$206K	4.33%	6
2014 Q2	$15.1M	Hold	274,052	–	–	3.49%	7
2014 Q1	$14.8M	Hold	274,052	–	–	3.99%	7
2013 Q4	$13.1M	Hold	274,052	–	–	3.72%	7
2013 Q3	$11.6M	Hold	274,052	–	–	3.78%	8
2013 Q2	$11.6M	Buy	+274,052	New	+$12.2M	3.87%	8

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bruce & Co's MRK Position: Q1 2026 in Review

Bruce & Co held its Merck (MRK) position steady in Q1 2026 at 192,800 shares worth $23.2M. The position accounts for 6.63% of the portfolio, ranked #5.

Bruce & Co first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.7M in Q2 2023. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Bruce & Co held 192,800 shares of Merck worth $23.2M as of Q1 2026.
Bruce & Co left its Merck share count unchanged in Q1 2026.
Merck made up 6.63% of Bruce & Co's portfolio in Q1 2026, its #5 holding.
Bruce & Co first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Bruce & Co's Merck position peaked at $34.7M in Q2 2023.
3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Bruce & Co's 13F filing for Q1 2026, filed 14 May 2026.